20524 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
Sub-classes:KRILL OIL FOR SOLUBILIZING POORLY WATER-SOLUBLE DIETARY SUPPLEMENTS AND PHARMACEUTICALLY ACTIVE AGENTS
#2PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#3MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
#4THERAPEUTIC DRUG COMBINATIONS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#5MACROLIDE SENOLYTIC COMPOUNDS
#6AZITHROMYCIN PREMIX FORMULATION AND PRODUCT, METHODS OF PREPARING SAME, AND METHODS OF USING SAME
#7COMPOSITIONS AND METHODS RELATED TO ANTI-CD19 ANTIBODY DRUG CONJUGATES
#8COMBINATION PREPARATIONS OF 3-N-FORMYLHYDROXYLAMINOPROPYL PHOSPHONIC ACID DERIVATIVES OR 3-N-ACETYLHYDROXYLAMINOPROPYL PHOSPHONIC ACID DERIVATIVES WITH CLINDAMYCIN AND ARTESUNATE
#9PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING ON DEMAND SOLID DOSAGE FORMULATIONS
#10METHODS FOR TREATING NEWLY DIAGNOSED MYCOBACTERIUM AVIUM COMPLEX LUNG INFECTIONS
#11METHODS OF DIAGNOSING OR TREATING LYME DISEASE
#12PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING ON DEMAND SOLID DOSAGE FORMULATIONS
#13PROSTANOID RECEPTOR AGONISTS AS NON-TUBERCULOUS ANTI-MYCOBACTERIAL AGENTS
#14INJECTABLE ANTIBIOTIC FORMULATIONS AND USES THEREOF
#15AZITHROMYCIN PREMIX FORMULATION AND PRODUCT, METHODS OF PREPARING SAME, AND METHODS OF USING SAME
#16COMBINATIONS OF MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST
#17METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS
#18METHODS AND PHARMACEUTICAL COMPOSITIONS TO TREAT RESPIRATORY DEPRESSION IN PATIENTS
#19COMBINATIONS
#20COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#21USE OF NUCLEOTIDE OF LACTOBACILLUS FERMENTUM GM-090 FOR PREPARING PHARMACEUTICAL COMPOSITION FOR REGULATING IMMUNITY
#22TREATMENT OF PATHOGENIC NEISSERIA SP. INFECTION WITH TRIAZOLE ANTIFUNGAL AGENTS
#23SYNTHETIC MULTIDOMAIN PEPTIDE BIOMATERIALS THAT INHIBIT INDUCIBLE NITRIC OXIDE SYNTHASE
#24PEPTIDE-BASED BIOMARKERS AND RELATED ASPECTS FOR DISEASE DETECTION
#25REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS
#26CRYSTAL FORMS OF BETA-NICOTINAMIDE MONONUCLEOTIDE
#27ULTRASOUND-RESPONSIVE NANOSCALE DELIVERY PLATFORM FOR USE IN THE TREATMENT OF BIOFILM-ASSOCIATED DISEASES
#28COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTION
#29AZITHROMYCIN AND ROXITHROMYCIN DERIVATIVES AS SENOLYTIC DRUGS
#30DRUG ELUTING POLYMER COMPOSED OF BIODEGRADABLE POLYMERS APPLIED TO SURFACE OF MEDICAL DEVICE
#31ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION
#32PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF
#33PYRIMIDINE COMPOUNDS CONTAINING ACIDIC GROUPS
#34METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS
#35PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#36IMMUNOSTIMULATORY COMPOSITIONS
#37SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES
#38MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE
#39Compound Tulathromycin Nanoemulsion, and Preparation Method and Use Thereof
#40Preventive Prescription Medication Combination Pack
#41FORMULATIONS AND METHODS FOR TREATING CONDITIONS OF THE EYE
#42METHODS FOR TREATING HAIR LOSS DISORDERS
#43METHODS FOR THE TREATMENT AND PREVENTION OF NON-VIRAL TICK-BORNE DISEASES AND SYMPTOMS THEREOF
#44REGENERATIVE AGENT FOR BONE TISSUE AND LUNG TISSUE, AND PHARMACEUTICAL COMPOSITION FOR REGENERATING BONE TISSUE AND LUNG TISSUE
#45METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS
#46HUMAN EFFICACIOUS DOSE AND DOSAGE SCHEDULE OF SPR720
#47PRODUCTION METHOD OF INNOVATIVE NANOFIBER MEDICAL TEXTILE MATERIAL WITH TRANSDERMAL- DRUG RELEASE PROPERTIES
#48Antigen Binding Molecules Targeting SARS-CoV-2
#49MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
#50NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND THEIR USES
#51COMPOSITIONS FOR ORAL CANCER OR AN OROPHARYNGEAL CANCER
#52TRIPLE COMBINATION THERAPIES FOR ANTI-AGING
#53INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF
#54Compounds for Treating Genetic Diseases
#55THERAPEUTIC AGENTS AND METHODS FOR TREATMENT OF BARTONELLOSIS
#56COMPOSITIONS AND METHODS FOR OVERCOMING MICROENVIRONMENT-MEDIATED RESISTANCE VIA E-SELECTIN TARGETING
#57NUCLEOSIDE COMPOUND AND APPLICATION THEREOF IN THE TREATMENT OF FELINE INFECTIOUS PERITONITIS
#58TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS
#59METHODS AND COMPOSITIONS FOR TREATING CANCER THERAPY-INDUCED NEUTROPENIC FEVER AND/OR GVHD
#60Azithromycin and roxithromycin derivtives as senolytic drugs
#61Method of Preventing and Treating COVID-19 Infection
#62COMBINATION THERAPY FOR TREATMENT OF CONDITIONS ASSOCIATED WITH AGING
#63TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS
#64METHOD OF TREATING A PERSON AFFLICTED WITH A RESPIRATORY CONDITION AND PHARMACEUTICAL FORMULATION INCLUDING DAPSONE
#65METHODS TO TREAT HEPATITIS DELTA VIRAL INFECTIONS
#66DRUGS, THERAPEUTIC COMBINATIONS AND METHODS FOR PREVENTING VIRAL AND MICROBIAL INFECTIONS AND THEIR SEQUELAE
#67COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST
#68COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#69METHODS FOR TREATING LUNG INFECTIONS AND INFLAMMATION
#70Antigen Binding Molecules Targeting SARS-CoV-2
#71Antigen binding molecules targeting SARS-CoV-2
#72COMPOSITIONS AND METHODS FOR THE TREATMENT OF BRONCHIOLITIS OBLITERANS
#73Methods for treating pulmonary non-tuberculous mycobacterial infections
#74COMPOSITIONS AND METHODS RELATED TO ANTI-CD19 ANTIBODY DRUG CONJUGATES
#75METHODS FOR TREATING NEWLY DIAGNOSED MYCOBACTERIUM AVIUM COMPLEX LUNG INFECTIONS
#76Injectable antibiotic formulations and use thereof
#77Compositions and methods for treating retinal degradation
#78Formulations and methods for treating conditions of the eye
#79COMPOSITIONS FOR THE TREATMENT OF A RESPIRATORY CONDITION
#80METHODS OF TREATMENT
#81INHIBITORS OF MICRO-RNA 22
#82OLEOGEL AND OLEOPASTE COMPOSITIONS AND USES THEREOF
#83ANTIBIOTIC AND ANTI-INFLAMMATORY COMPOSITIONS AND METHODS OF USE
#84THERAPEUTIC METHODS FOR PREVENTING TUMOR METASTASIS AND TUMOR RECURRENCE
#85COMPOUNDS AND METHODS FOR REDUCTION OF CANCER CELL BURDEN AND PROTECTION OF NORMAL HEMATOPOIESIS
#86Nicotinamide mononucleotide derivatives and their uses
#87Methods of Inhibiting SARS-CoV-2 Replication and Treating Corona Virus Disease 2019
#88CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF COVID-19
#89IMMUNOMODULATING TRIFLUOROMETHYL-AMINAL AZALIDES
#90IMMUNOMODULATING O-HET/ARYL AZALIDES
#91ANTI-INFECTIVE AND ANTI-VIRAL COMPOUNDS AND COMPOSITIONS
#92PEPTIDES AND ADJUVANTS FOR AUGMENTATION OF FIBROBLAST THERAPY FOR CORONAVIRUS
#93COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL
#94STING AGONIST COMBINATION TREATMENTS WITH CYTOKINES
#95USES OF TAXIFOLIN FOR RESPIRATORY HEALTH
#96COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS
#97Methods for treating hair loss disorders
#98Opthalmic Compositions for Treating Coronaviruses
#99COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS
#100COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION OF ANTIBIOTICS
#101Methods For Treating Coronavirus Disease
#102PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#103METHODS AND COMPOSITIONS FOR TREATING MELANOMA
#104Stimulation of Human Meibomian Gland Function
#105Methods for treating hair loss disorders
#106Methods for treating pulmonary non-tuberculous mycobacterial infections
#107NAD(H) NANOPARTICLES AND METHODS OF USE
#108Method of treating a person afflicted with COVID-19 and pharmaceutical formulation including dapsone
#109NUCLEOTIDE DERIVATIVES AND METHODS OF USE THEREOF
#110URIDINE DIPHOSPHATE DERIVATIVES, PRODRUGS, COMPOSITIONS AND USES THEREOF
#111FLUID DELIVERY DEVICES AND METHODS
#112COMBINATION PREPARATIONS OF 3-N-FORMYLHYDROXYLAMINOPROPYL PHOSPHONIC ACID DERIVATIVES OR 3-N-ACETYLHYDROXYLAMINOPROPYL PHOSPHONIC ACID DERIVATIVES WITH CLINDAMYCIN AND ARTESUNATE
#113Methods for treating pulmonary non-tuberculous mycobacterial infections
#114COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND/OR TREATMENT OF DYSBIOSIS AND ANTIBACTERIAL ANTIDOTES FOR MICROBIOME-PROTECTION
#115MULTI-LAYERED NANOPARTICLE COATED SUBSTRATES FOR DRUG DELIVERY
#116Galactoside inhibitor of galectins
#117UV BLOCKING COMPOSITION COMPRISING RED ALGAE-DERIVED FLORIDOSIDE AND AMINE GROUP-CONTAINING COMPOUND
#118Formulations and methods for treating conditions of the eye
#119SEQUENCE-SPECIFIC IN VIVO CELL TARGETING
#120Method for treating coronavirus infections including SARS-CoV-2
#121ATOVAQUONE NANOPARTICULATE COMPOSITIONS
#122Compositions and Methods for Monitoring, Diagnosis, Detection and Treatment of Cancer
#123Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer
#124MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE
#125METHOD AND COMBINATION FOR TREATING VIRAL INFECTION AND LONG HAULER SYNDROME
#126MODULATORS OF TELOMERE DISEASE
#127PROCESSES AND AGENTS FOR GLAUCOMA
#128ALKYL-TPP COMPOUNDS FOR MITOCHONDRIA TARGETING AND ANTI-CANCER TREATMENTS
#129Therapeutics and methods for predicting and overcoming endocrine resistance in breast cancer
#130USES OF A2 DOMAIN OF VON WILLEBRAND FACTOR
#131COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING VIRAL INFECTIONS
#132Formulations and methods for treating conditions of the eye
#133METHODS FOR DETECTING LEGIONELLA
#134Carbohydrate conjugates as delivery agents for oligonucleotides
#135METHODS OF PREVENTING AND TREATING COVID-19 INFECTION
#136COMPOSITIONS AND METHODS FOR TREATMENT OF A CORONAVIRUS DISEASE (COVID-19) INFECTION
#137Methods of treatment
#138CRYSTAL FORMS OF BETA-NICOTINAMIDE MONONUCLEOTIDE
#139USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF TRAUMATIC INJURY
#140Methods of treatment
#141Ophthalmic Drug Compositions
#142COMBINATION IN THE TREATMENT OF NONTUBERCULOUS MYCOBACTERIAL DISEASES
#143Compositions and methods for detection and treatment of coronavirus infection
#144DETECTION OF DNA SEQUENCES AS RISK FACTORS FOR HIV INFECTION
#145Injectable antibiotic formulations and use thereof
#146Compositions for Broad Spectrum Topical Antimicrobials
#147Triple combination therapies for anti-aging
#148Carbohydrate conjugates as delivery agents for oligonucleotides
#149Pyrrolopyrimidine nucleosides and analogs thereof
#150PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING ON DEMAND SOLID DOSAGE FORMULATIONS
#151Modulators of 5′-nucleotidase, ecto and the use thereof
#152Dapsone formulations and methods of using same
#153ANTIMICROBIAL, BACTERIOPHAGE-DERIVED POLYPEPTIDES AND THEIR USE AGAINST GRAM-NEGATIVE BACTERIA
#154PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#155THERAPEUTIC COMPOSITIONS, PRODUCTS OF MANUFACTURE AND METHODS FOR AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#156BIODEGRADABLE DRUG DELIVERY COMPOSITION
#157Methods of preventing and treating COVID-19 infection
#158METHODS OF PREVENTING AND TREATING COVID-19 INFECTION
#159Methods of treating COVID-19 infection
#160Method of preventing COVID-19 infection
#161Compositions for oral cancer or an oropharyngeal cancer
#162Methods to Expand the Spectrum of Gram-Positive Antibiotics
#163Azithromycin and roxithromycin derivatives as senolytic drugs
#164Materials and methods for inhibiting flavivirus infection
#165COMPOSITION CONTAINING BECLOMETHASONE FOR THE PREVENTION AND THE TREATMENT OF BACTERIAL PROSTATITIS AND VAGINITIS
#166Methods of treating and prognosing nonhematopoietic malignant tumors
#167ANTI-VIRAL COMPOSITIONS AND METHODS OF USE
#168THERAPEUTIC COMBINATIONS OF DRUGS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#169THERAPEUTIC COMPOSITIONS, PRODUCTS OF MANUFACTURE AND METHODS FOR AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#170Methods for treating pulmonary non-tuberculous mycobacterial infections
#171Synthetic multidomain peptide biomaterials that inhibit inducible nitric oxide synthase
#172Method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents
#173Compositions, Methods and/or Devices for Prevention and/or Treatment of Dry Eye Disorders
#174Phosphor(n)amidatacetal and phosph(on)atalcetal compounds
#175Drug eluting polymer composed of biodegradable polymers applied to surface of medical device
#176Methods for inhibiting microbe growth
#177Radiation-Sterilized Biodegradable Drug Delivery Compositions
#178Utilizing polymers and antibiotics to enhance antimicrobial activity and inhibit antibiotic resistance
#179Substituted nucleosides, nucleotides and analogs thereof
#180INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF
#181Compositions and methods for treating retinal degradation
#182Sequence-specific in vivo cell targeting
#183Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#184COMPOSITIONS FOR TREATING INFECTIVE ARTERIAL DISEASES AND RELATED CONDITIONS
#185Method of enhancing the antimicrobial action of systemically administered antibiotics
#186Method of Manufacturing an antiviral super treatment
#187METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL
#188Kits and methods for assessing a condition or a risk of developing a condition, and related methods of treatment
#189METHODS FOR TREATING INFLAMMATORY DISEASES
#190Modulators of 5′-nucleotidase, ecto and the use thereof
#191Substituted pyrimidines containing acidic groups as TLR7 modulators
#192MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE
#193METHODS FOR THE TREATMENT OF ROSACEA
#194KRILL OIL FOR SOLUBILIZING POORLY WATER-SOLUBLE DIETARY SUPPLEMENTS AND PHARMACEUTICALLY ACTIVE AGENTS
#195Methods and compositions for treatment of multi-drug resistant tumors
#196Composition and methods of treating acne and photoaging
#197INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF
#198Nicotinamide mononucleotide derivatives and their uses
#199Methods for treating pulmonary non-tuberculous mycobacterial infections
#200ONCOLYTIC CANCER IMMUNOTHERAPIES AND METHODS OF USE
#201HALOALKYL FUCOSE-CONTAINING SELECTIN ANTAGONISTS
#202Carbohydrate conjugates as delivery agents for oligonucleotides
#203STIMULATION OF HUMAN MEIBOMIAN GLAND FUNCTION
#204Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure
#205Antibacterial compounds and methods of use thereof
#206Oligonucleotide compositions and methods for treating diseases
#207Application of Macrolide Antibiotic in Blocking Influenza Virus Infection
#208Methods for treating pulmonary non-tuberculous mycobacterial infections
#209Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage
#210Methods for treating hair loss disorders
#211Pyrrolopyrimidine nucleosides and analogs thereof
#212TRPA1 ANTAGONISTS FOR TREATMENT OF DRY EYE, OCULAR PAIN AND INFLAMMATION
#213Ibandronate conjugates of nucleoside antimetabolites
#214Crystal forms of β-nicotinamide mononucleotide
#215Drug formulations
#216DISPENSING CAP CONTAINING A SOLUBILISATE OF A PHARMACEUTICALLY ACTIVE AGENT OR DIETARY SUPPLEMENT
#217METHODS TO TREAT ALLERGIC CONDITIONS
#218Utilizing polymers and antibiotics to enhance antimicrobial activity and inhibit antibiotic resistance
#219Compositions and methods related to anti-CD19 antibody drug conjugates
#220Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
#221Nucleotide derivatives and methods of use thereof
#222Morpholino oligonucleotide manufacturing method
#223Methods for treating pulmonary non-tuberculous mycobacterial infections
#224Kinase inhibitors
#225Substituted pyrimidines containing acidic groups as TLR7 modulators
#226Modulators of 5′-nucleotidase, ecto and the use thereof
#227Advanced methods and systems for treating cell proliferation disorders
#228Delivery Scaffolds and Related Methods of Use
#229Methods for treating hair loss disorders
#230Compositions and Methods for Treating an Infection
#231Compositions and methods for treating retinal degradation
#232EXTRACELLULAR TARGETED DRUG CONJUGATES
#233Antimicrobial composition combinations comprising star shaped peptide polymers
#234Cancer chemotherapy employing halogenated analogs of thymidine
#235Treatment Method by Combined Use of MDM2 Inhibitor and DNA Methyltransferase Inhibitor
#236Methods of treating a wound using epigenetic regulation
#237Crystal forms of beta-nicotinamide mononucleotide
#238Injectable antibiotic formulations and use thereof
#239Methods for treating pulmonary non-tuberculous mycobacterial infections
#240Modulators of telomere disease
#241Biodegradable Drug Delivery Composition
#242Detection of DNA sequences as risk factors for HIV infection
#243SPR741 HUMAN PHARMACOKINETICS AND EFFICACIOUS DOSE
#244Carbohydrate conjugates as delivery agents for oligonucleotides
#245Methods for treating pulmonary non-tuberculous mycobacterial infections
#246METHODS AND PHARMACEUTICAL COMPOSITIONS OF THE TREATMENT OF AUTISTIC SYNDROME DISORDERS
#247SYSTEM AND METHOD FOR DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS
#248Mannose-derived antagonists of FimH useful for treating disease
#249Targeting Lipids
#250APPARATUS AND METHOD FOR MAGNETIC DELIVERY OF DRUGS DEEP INTO ARTICULAR CARTILAGE FOR OSTEOARTHRITIS
#251Potentiated tulathromycin
#252Crystal forms of beta-nicotinamide mononucleotide
#253Radiation - Sterilized Biodegradable Drug Delivery Compositions
#254Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome
#255Substituted nucleosides, nucleotides and analogs thereof
#256Pharmaceutical composition for treating and/or preventing cancer
#257Dicaffeoyl spermidine cyclized derivatives and use thereof
#258Antibacterial compounds and methods of use thereof
#259Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders
#260METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#261Drug formulations
#262METHODS FOR TREATING RESISTANT DISEASES USING TRIAZOLE CONTAINING MACROLIDES
#263DIAGNOSIS AND TREATMENT OF INFECTIOUS DISEASE
#264BONE TARGETED THERAPEUTICS AND METHODS OF MAKING AND USING THE SAME
#265Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
#266Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs
#267CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES
#268Kinase inhibitors
#269Compositions and methods of treating acne and photoaging
#270Methods for treating pulmonary non-tuberculous mycobacterial infections
#271Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
#272TARGETED THERAPEUTIC NUCLEOSIDES AND THEIR USE
#273Crystal forms of β-nicotinamide mononucleotide
#274Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#275SINGLE SOLID ORAL DOSAGE FORMS FOR TREATING HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE
#276INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF
#277Ophthalmic Drug Compositions
#278METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL
#279Forazolines, compositions thereof and uses thereof
#280METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#281METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUSES AND PESTIVIRUSES
#282Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure
#283Therapeutic agent for myotonic dystrophy
#284Use of levocetirizine and montelukast in the treatment of traumatic injury
#285Substituted pyrimidines containing acidic groups as TLR7 modulators
#286Nicotinamide mononucleotide derivatives and their uses
#287METHODS FOR THE TREATMENT OF ROSACEA
#288Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof
#289Substituted nucleosides, nucleotides and analogs thereof
#290ANTIBACTERIAL INJECTABLE PHARMACEUTICAL COMPOSITION
#291Advanced methods and systems for treating cell proliferation disorders
#292Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage
#293Methods for treating hair loss disorders
#294Methods to treat allergic conditions with PIM1 kinase inhibitor
#295Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer
#296Methods of treating and prognosing nonhematopoietic malignant tumors
#297Methods for treating pulmonary non-tuberculous mycobacterial infections
#298TREATMENT OF OCULAR DISORDERS
#299Treatment of Drug-Resistant Microbial Infections
#300Targeted Delivery Platform for Delivery of Therapeutics